Sylvia Borchers

发表

Cytomegalovirus-specific CD8+ T-cells are associated with a reduced incidence of early relapse after allogeneic stem cell transplantation

A. Ganser, E. Weissinger, J. Ogonek, 2019, PloS one.

Possible Impact of Cytomegalovirus-Specific CD8+ T Cells on Immune Reconstitution and Conversion to Complete Donor Chimerism after Allogeneic Stem Cell Transplantation.

A. Ganser, E. Weissinger, G. Göhring, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impaired Functionality of Antiviral T Cells in G-CSF Mobilized Stem Cell Donors: Implications for the Selection of CTL Donor

A. Ganser, E. Weissinger, R. Blasczyk, 2013, PloS one.

Evaluation of suitable target antigens and immunoassays for high-accuracy immune monitoring of cytomegalovirus and Epstein-Barr virus-specific T cells as targets of interest in immunotherapeutic approaches.

R. Blasczyk, B. Maecker-Kolhoff, B. Eiz-Vesper, 2014, Journal of immunological methods.

Multimer monitoring of CMV-specific T cells in research and in clinical applications.

E. Weissinger, B. Eiz-Vesper, U. Koehl, 2014, Diagnostic microbiology and infectious disease.

Expansion of recipient‐derived antiviral T cells may influence donor chimerism after allogeneic stem cell transplantation

A. Ganser, E. Weissinger, T. Ganzenmueller, 2013, Transplant infectious disease : an official journal of the Transplantation Society.

Reconstitution and Phenotype of Tregs in CMV Reactivating Patients Following Allogeneic Hematopoietic Stem Cell Transplantation

A. Ganser, E. Mischak-Weissinger, S. Buchholz, 2013, Immunological investigations.

Tetramer monitoring to assess risk factors for recurrent cytomegalovirus reactivation and reconstitution of antiviral immunity post allogeneic hematopoietic stem cell transplantation

A. Ganser, E. Mischak-Weissinger, U. Koehl, 2011, Transplant infectious disease : an official journal of the Transplantation Society.

CMV-, EBV- and ADV-specific T cell immunity: screening and monitoring of potential third-party donors to improve post-transplantation outcome.

E. Mischak-Weissinger, A. Heim, H. Heuft, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Genetically modified donor leukocyte transfusion and graft-versus-leukemia effect after allogeneic stem cell transplantation.

A. Ganser, E. Weissinger, Wolfgang Kuehnau, 2011, Human gene therapy.

Integrase-defective lentiviral vectors encoding cytokines induce differentiation of human dendritic cells and stimulate multivalent immune responses in vitro and in vivo.

A. Schambach, A. Ganser, E. Weissinger, 2012, Vaccine.

Long term follow up of patients after allogeneic stem cell transplantation and transfusion of HSV-TK transduced T-cells

A. Ganser, E. Weissinger, Wolfgang Kuehnau, 2015, Front. Pharmacol..

Sequential Anti-Cytomegalovirus Response Monitoring May Allow Prediction of Cytomegalovirus Reactivation after Allogeneic Stem Cell Transplantation

A. Ganser, E. Weissinger, T. Klingebiel, 2012, PloS one.

Lentivirus-induced dendritic cells for immunization against high-risk WT1(+) acute myeloid leukemia.

A. Schambach, R. Geffers, A. Ganser, 2013, Human gene therapy.

Preconditioning therapy with lentiviral vector-programmed dendritic cells accelerates the homeostatic expansion of antigen-reactive human T cells in NOD.Rag1-/-.IL-2rγc-/- mice.

Adan Chari Jirmo, A. Ganser, D. Wedekind, 2011, Human gene therapy.